Horizon Therapeutics (HZNP) Misses Q1 EPS by 37c

Horizon Therapeutics (NASDAQ: HZNP) reported Q1 EPS of $0.83, $0.37 worse than the analyst estimate of $1.20. Revenue for the quarter came in at $832.1 million versus the consensus estimate of $914.83 million.

For earnings history and earnings-related data on Horizon Therapeutics (HZNP) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Aon names interim CFO as Edmund Reese exits the firm
• INVO Fertility (IVF) Tops Q2 EPS by 105c